Literature DB >> 11849624

Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women.

J K Scariano1, P J Garry, G D Montoya, J M Wilson, R N Baumgartner.   

Abstract

OBJECTIVES: The purpose of this investigation was to quantify the biologic, day-to-day variability and critical differences in serum levels of crosslinked collagen N-telopeptides (NTx), procollagen aminoterminal extension propeptides (PINP) and bone specific alkaline phosphatase (bAP) in healthy women. DESIGN AND METHODS: Seven blood samples were collected from 12 pre- and 15 postmenopausal women over 4 to 6 months. NTx, PINP and bAP levels were determined utilizing enzyme- and radioimmunoassay techniques.
RESULTS: The within-subject coefficient of variation (C.V.) in serum bAP, NTx and PINP levels was 7.1, 10.6 and 12.4% respectively. These variances did not differ significantly among premenopausal women when compared with postmenopausal subjects. Combining terms for analytical and biologic variability revealed that a critical difference between 2 successive serial measurements is 24% for bAP, 34% for NTx and 38% for PINP.
CONCLUSION: Circulating levels of NTx, PINP and bAP are stable over time periods of several months, allowing for the determination of significant changes in skeletal metabolism of women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11849624     DOI: 10.1016/s0009-9120(01)00273-9

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.

Authors:  J S Bubbear; A Gall; F R I Middleton; M Ferguson-Pell; R Swaminathan; R W Keen
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

2.  Serum pentosidine concentration is associated with radiographic severity of lumbar spondylosis in a general Japanese population.

Authors:  Daisuke Chiba; Kanichiro Wada; Toshihiro Tanaka; Gentaro Kumagai; Eiji Sasaki; Ippei Takahashi; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  J Bone Miner Metab       Date:  2015-12-11       Impact factor: 2.626

3.  Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients.

Authors:  Sunita Sardiwal; Clare Gardham; Adrian E Coleman; Paul E Stevens; Michael P Delaney; Edmund J Lamb
Journal:  Kidney Int       Date:  2012-03-28       Impact factor: 10.612

4.  Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice.

Authors:  Danielle A Eekman; Irene E M Bultink; Annemieke C Heijboer; Ben A C Dijkmans; Willem F Lems
Journal:  BMC Musculoskelet Disord       Date:  2011-07-21       Impact factor: 2.362

Review 5.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.